SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
-15.65%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$215M
AUM Growth
+$215M
(-11%)
Cap. Flow
+$11.5M
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
74.42%
Holding
31
New
3
Increased
13
Reduced
8
Closed
6
Top Buys
| 1 |
AFMD
Affimed
AFMD
|
$8.71M |
| 2 |
Rezolute
RZLT
|
$7.28M |
| 3 |
UroGen Pharma
URGN
|
$6.9M |
| 4 |
Castle Biosciences
CSTL
|
$6.48M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$5.87M |
Top Sells
| 1 |
ATRS
Antares Pharma, Inc.
ATRS
|
$12.8M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
$8.54M |
| 3 |
Evolus
EOLS
|
$6.58M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$5.99M |
| 5 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$2.24M |
Sector Composition
| 1 | Healthcare | 95.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $44M | 20.48% | 6,298,348 -39,852 | -0.6% | -$279K |
|
|
CTIC
2
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $22M | 10.23% | 3,681,195 -1,003,209 | -21% | -$5.99M |
|
3
Xeris Biopharma Holdings
XERS
$1.26B
| $17.9M | 8.35% | 11,647,417 +3,723,361 | +47% | +$5.73M |
|
4
ADMA Biologics
ADMA
$4.12B
| $13.9M | 6.45% | 7,000,000 -131,808 | -2% | -$261K |
|
|
AMRN
5
Amarin Corp
AMRN
$311M
| $13.2M | 6.14% | 8,853,763 +3,941,049 | +80% | +$5.87M |
|
6
QuidelOrtho
QDEL
$1.95B
| $11.6M | 5.42% | 119,787 +57,996 | +94% | +$5.64M |
|
|
7
Rezolute
RZLT
$619M
| $9.7M | 4.51% | 3,001,926 +2,253,224 | +301% | +$7.28M |
|
|
OPTN
8
DELISTED
OptiNose
OPTN
| $9.58M | 4.46% | 2,616,515 -309,901 | -11% | -$1.13M |
|
|
9
UroGen Pharma
URGN
$900M
| $9.1M | 4.23% | 1,111,050 +842,217 | +313% | +$6.9M |
|
10
Ligand Pharmaceuticals
LGND
$3.15B
| $8.94M | 4.16% | 100,244 +26,544 | +36% | +$2.37M |
|
|
AFMD
11
DELISTED
Affimed
AFMD
| $8.71M | 4.05% | +3,143,773 | New | +$8.71M |
|
|
APEN
12
DELISTED
Apollo Endosurgery, Inc.
APEN
| $7.89M | 3.67% | 2,161,999 +468,165 | +28% | +$1.71M |
|
13
Ovid Therapeutics
OVID
$91M
| $7.5M | 3.49% | 3,487,928 -730,141 | -17% | -$1.57M |
|
14
Exagen
XGN
$217M
| $7.24M | 3.37% | 1,260,387 +139,347 | +12% | +$800K |
|
|
15
Castle Biosciences
CSTL
$696M
| $6.48M | 3.02% | +295,372 | New | +$6.48M |
|
|
CFMS
16
DELISTED
Conformis, Inc. Common Stock
CFMS
| $6.12M | 2.85% | 17,304,350 +22,964 | +0.1% | +$8.12K |
|
17
DiaMedica Therapeutics
DMAC
$295M
| $2.38M | 1.11% | 1,176,344 -20,901 | -2% | -$42.2K |
|
|
AERI
18
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.88M | 0.88% | 251,235 +157,335 | +168% | +$1.18M |
|
|
OPNT
19
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $1.83M | 0.85% | +152,278 | New | +$1.83M |
|
|
ATYR
20
aTyr Pharma
ATYR
$527M
| $1.7M | 0.79% | 601,580 | – | – |
|
|
MRNS
21
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.17M | 0.55% | 242,327 +185,580 | +327% | +$898K |
|
22
Xoma
XOMA
$392M
| $1.02M | 0.48% | 45,910 +9,107 | +25% | +$203K |
|
23
ANI Pharmaceuticals
ANIP
$2.03B
| $854K | 0.4% | 28,800 +2,740 | +11% | +$81.2K |
|
24
Synlogic
SYBX
$17M
| $107K | 0.05% | 92,746 -971,389 | -91% | -$1.12M |
|
25
Cidara Therapeutics
CDTX
$1.66B
| $102K | 0.05% | 208,443 -2,288,077 | -92% | -$1.12M |
|